JNJ is running a phase-2 trial in IPF (info c/o ‘Germanecki’ on SI): <a href="http://clinicaltrials.gov/ct2/show/NCT00786201" target="_blank">http://clinicaltrials.gov/ct2/show/NCT00786201</a>